Elaia — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
Aqemia applies atomic-scale physics and generative AI to accelerate drug discovery and molecular design, enabling faster identification of innovative medicines for unmet therapeutic needs.
AI & Machine LearningBiotechDeep Tech
Maximilien Levesque(PhD, Prof., CEO and Co-Founder)Emmanuelle Martiano-Rolland(COO and Co-Founder)
Co-investorsCathay InnovationPSL Innovation FundBpifranceEurazeo
dottxt builds tools to make large language models composable and reliable by enforcing schemas and contracts, enabling AI systems to behave predictably like traditional software.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareJersey City, US
Rémi Louf(Executive Officer, Director)inBrandon T. Willard(Director)Daniel Gerlanc(Executive Officer, Director)
BoardJulien Hobeika(Director)Clement Vanden Driessche(Director)in
Co-investorsKima VenturesScript CapitalCommon MagicEQT Ventures
Dunia operates an autonomous materials acceleration platform called IRIS that combines robotics, AI foundation models, and experimental data to speed up the discovery of new materials, beginning with energy applications.
AI & Machine LearningDeep TechNew Materials
Marcus Tze-Kiat Ng(Founder)in
Co-investorsDeep Science VenturesKindred CapitalPace VenturesEICredalpine
NanoCorp builds autonomous AI agents that create and operate full companies from a single natural language prompt, handling product development, website deployment, customer acquisition, payments, and operations without requiring code or a team.
AI & Machine LearningConsumerCreator EconomySaaSSan Francisco, US
Pierre-Louis Biojout(Founder)in
Co-investorsY Combinator
phospho builds AI models to control real-world robots and provides an open-source, developer-focused robotics toolkit.
AI & Machine LearningDeveloper ToolsRobotics
Co-investorsKima VenturesY Combinator
Qantev builds AI software that helps large insurers manage and optimize their health and life claims operations.
AI & Machine LearningDigital HealthInsurTechParis, FR
Tarik Dadi(CEO)inHadrien De March(CTO)in
Co-investorsBlossom CapitalOmnes CapitalEntrepreneur FirstPSL Innovation FundRAISE
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.